Combined association of serum uric acid and metabolic syndrome with chronic kidney disease in hypertensive patients

Kidney and Blood Pressure Research

Volumn 41, Issue 4, 2016, Pages 413-423

  Dai, Haijiang ^a   Lu, Shijuan ^a   Tang, Xiaohong ^a   Lu, Minggen ^b   Chen, Ruifang ^a   Chen, Zhiheng ^a   Yang, Pingting ^a   Liu, Chang ^a   Zhou, Honghao ^a   Lu, Yao ^a   Yuan, Hong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Hypertension; Hyperuricemia; Metabolic syndrome; Serum uric acid

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL OBESITY; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SERUM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID;

EID: 84976587102     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000443443     Document Type: Article

References (33)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2224-2260.
2. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet 2015; 386: 801-812.
3. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: A global challenge. Kidney Int Suppl 2005: S11-17.
4. Ming J, Xu S, Yang C, Gao B, Wan Y, Xing Y, Zhang L, Yang W, Ji Q; China National Diabetes and Metabolic Disorders Study Group. Metabolic syndrome and chronic kidney disease in general chinese adults: Results from the 2007-08 china national diabetes and metabolic disorders study. Clin Chim Acta 2014; 430: 115-120.
5. Kang YU, Kim HY, Choi JS, Kim CS, Bae EH, Ma SK, Kim SW. Metabolic syndrome and chronic kidney disease in an adult korean population: Results from the korean national health screening. PloS one 2014; 9: e93795.
6. Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, Batuman V, Lee CH, Whelton PK, He J. Association between the metabolic syndrome and chronic kidney disease in chinese adults. Nephrology, dialysis, transplantation :official publication of the European Dialysis and Transplant Association - European Renal Association 2007; 22: 1100-1106.
7. Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, Bhuiyan AR, Jenkins BC, Addison C. The association between individual and combined components of metabolic syndrome and chronic kidney disease among african americans: The jackson heart study. PloS one 2014; 9: e101610.
8. Zomorrodian D, Khajavi-Rad A, Avan A, Ebrahimi M, Nematy M, Azarpazhooh MR, Emamian M, Sadeghzade M, Mirhafez SR, Mohammadi M, Mousavi M, Esmaeili H, Moohebati M, Parizadeh MR, Ferns GA, Ghayour-Mobarhan M. Metabolic syndrome components as markers to prognosticate the risk of developing chronic kidney disease: Evidence-based study with 6492 individuals. J Epidemiol Community Health 2015; 69: 594-598.
9. Leoncini G, Viazzi F, Agabiti Rosei E, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R. Metabolic syndrome and chronic kidney disease in high-risk italian hypertensive patients: The I-demand study. J Nephrol 2012; 25: 63-74.
10. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation 2005; 112: 2735-2752.
11. Yu S, Guo X, Yang H, Zheng L, Sun Y. Metabolic syndrome in hypertensive adults from rural northeast china: An update. BMC Public Health 2015; 15: 247.
12. Grassi D, Ferri L, Desideri G, Di Giosia P, Cheli P, Del Pinto R, Properzi G, Ferri C. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 2013; 19: 2432-2438.
13. Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens 2015; 33: 1729-1741; discussion 1741.
14. Tian Y, Chen K, Xie Z, Fang Y, Wang H, Nie Y, Hu D, Mu Y. The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly chinese: Results from the dyslipidemia international study. BMC Cardiovasc Disord 2015; 15: 66.
15. Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC. Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J Clin Hypertens (Greenwich) 2009; 11: 253-259.
16. Satirapoj B, Supasyndh O, Chaiprasert A, Ruangkanchanasetr P, Kanjanakul I, Phulsuksombuti D, Utainam D, Choovichian P. Relationship between serum uric acid levels with chronic kidney disease in a southeast asian population. Nephrology (Carlton) 2010; 15: 253-258.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate Ann Intern Med 2009 150 604-612.
19. Chuang SY, Wu CC, Hsu PF, Chia-Yu Chen R, Liu WL, Hsu YY, Pan WH. Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in taiwan. Nutr Metab Cardiovasc Dis 2014; 24: 1020-1026.
20. Odagiri K, Mizuta I, Yamamoto M, Miyazaki Y, Watanabe H, Uehara A. Waist to height ratio is an independent predictor for the incidence of chronic kidney disease. PloS one 2014; 9: e88873.
21. Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Iseki C, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kimura K, Asahi K, Kurahashi I, Ohashi Y, Watanabe T. New-onset hypertension and risk for chronic kidney disease in the japanese general population. J Hypertens 2014; 32: 2371-2377; discussion 2377.
22. Toyama T, Furuichi K, Shimizu M, Hara A, Iwata Y, Sakai N, Perkovic V, Kobayashi M, Mano T, Kaneko S, Wada T. Relationship between serum uric acid levels and chronic kidney disease in a japanese cohort with normal or mildly reduced kidney function. PloS one 2015; 10: e0137449.
23. Zhu P, Liu Y, Han L, Xu G, Ran JM. Serum uric acid is associated with incident chronic kidney disease in middle-Aged populations: A meta-Analysis of 15 cohort studies. PloS one 2014; 9: e100801.
24. Litwin M, Feber J, Niemirska A, Michalkiewicz J. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatr Nephrol 2016; 31: 185-194.
25. Sanchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, Franco M, Rodriguez-Iturbe B, Johnson RJ. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008; 295: F1134-1141.
26. Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005; 67: 237-247.
27. Uedono H, Tsuda A, Ishimura E, Yasumoto M, Ichii M, Ochi A, Ohno Y, Nakatani S, Mori K, Uchida J, Nakatani T, Inaba M. Relationship between serum uric acid levels and intrarenal hemodynamic parameters. Kidney Blood Press Res 2015; 40: 315-322.
28. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-Angiotensin system. J Hypertens 2008; 26: 269-275.
29. Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, Roncal C, Johnson RJ, Nakagawa T. Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol 2009; 297: F481-488.
30. Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol 2013; 304: F471-480.
31. Song H, Wang X, Cai Q, Ding W, Huang S, Zhuo L. Association of metabolic syndrome with decreased glomerular filtration rate among 75, 468 chinese adults. A cross-sectional study. PloS one 2014; 9: e113450.
32. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in u.S. Adults. Ann Intern Med 2004; 140: 167-174.
33. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander. Metabolism 2006; 55: 1293-1301.